Medicinal composition for treating coronary heart disease

Abstract

The present invention discloses a kind of medicinal composition containing liposoluble red sage extract, notoginseng extract and dalbergia wood oil, and its preparation process and use in preparing medicine for treating coronary heart disease.

Description

technical field [0001] The invention relates to a medicinal composition comprising fat-soluble extract of salvia miltiorrhiza, extract of notoginseng and balm oil and its medical application. Background technique [0002] According to statistics released by the Ministry of Health, in 1957, the death rate of cardiovascular and cerebrovascular diseases among urban residents accounted for 12.0% of the total deaths, which rose to 16.6% in 1989, and the ranking of the cause of death rose from the fifth and sixth to the second and third. In recent years, the mortality rates of cerebrovascular disease and cardiovascular disease in my country are 134.88 / 100,000 and 99.99 / 100,000 respectively, accounting for 22.63% and 16.77% of the total deaths; The first cause of death is 27.53% of all deaths, of which heart disease is 21.67%. It is estimated that by 2010, the death rate of cardiovascular and cerebrovascular diseases in Beijing will reach 306.2 / 100,000, while coronary heart disease ...

AI Technical Summary

Problems solved by technology

At present, the varieties of traditional Chinese medicines with single effective parts, especially the injections with effective parts of traditional Chinese medicines such as Xuesaitong, Xueshuantong, etc., are difficult to meet the needs of clinical combination drugs

In addition, simply mixing traditional Chinese medicine injections without the approval of the State Drug and Food Administration will take a huge risk and may cause unexpected adverse reactions, such as a sharp increase in blood pressure, fever, allergic reactions, etc.